STAT+: Pharmalittle: Lawmakers urge FTC to probe blood thinner prices; EU pressures Covid vaccine makers to renegotiate contracts

Top of the morning to you. Gray skies are hovering over the Pharmalot campus right now, but our spirits remain sunny, nonetheless. Why? We will trot out a bit of insight from the Morning Mayor, who would say, “Every new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and invite you to join us. Our choice today is an old standby: hazelnut. And remember, a prescription is not required, so need to calculate rebates. Meanwhile, here are a few items of interest. Hope you have a smashing day and, of course, do stay in touch …

European Union governments are intensifying pressure on Pfizer and other Covid-19 vaccine makers to renegotiate contracts, warning millions of shots that are no longer needed could go to waste, Reuters reports. During the most acute phase of the pandemic, the European Commission and EU governments agreed to buy huge volumes of vaccines, mostly from Pfizer and its partner BioNTech, amid fears of insufficient supplies. But with the pandemic abating in Europe and amid a marked slowdown in vaccinations, many countries are now urging tweaks to contracts to reduce supplies and consequently cut their spending on vaccines.

Continue to STAT+ to read the full story…